Ontada and Microsoft Join Forces for Revolutionary Oncology Data
Ontada Partners with Microsoft to Enhance Oncology Data Analytics
Ontada, a McKesson business focused on oncology real-world data and clinical insights, is teaming up with Microsoft to harness the power of Azure AI, specifically the Azure OpenAI Service. This collaboration aims to revolutionize the processing of over 150 million unstructured oncology document components. By efficiently handling such a vast amount of data, Ontada seeks to unlock critical clinical information that can lead to better patient care.
Transforming Unstructured Data into Actionable Insights
In the realm of healthcare, an overwhelming challenge faced by systems today is that nearly 80% of crucial data remains unstructured. This unstructured data includes clinical notes, lab test results, medical imaging, and financial records. Astonishingly, it’s estimated that around 97% of this valuable information often goes unexamined or ignored.
The Role of AI in Oncology
To combat the problem of unstructured data, the Ontada Data Science team has taken proactive measures by deploying Large Language Models (LLMs). These models are specifically designed to target approximately 100 essential oncology data elements spanning 39 different types of cancer. This initiative not only aims to streamline data processing but also aspires to enhance the quality and accuracy of patient information.
Expert Insights on Advanced Technologies
Tyler Bryson, Corporate Vice President of US Health & Public Sector Industries at Microsoft, shared his views on the collaboration, stating, "Our partnership with Ontada provides essential insights into what Microsoft Azure AI can achieve. We believe there’s immense potential to exponentially increase the processing power for this important data. Collaborating closely, we’ve seen remarkable improvements in Ontada's ability to access and utilize valuable clinical data.”
Innovative Solutions for Oncology Care
Ontada’s partnership with Microsoft represents a commitment to developing a robust and sustainable data platform for their clients. Their ON.Genuity platform merges innovative AI technology with an advanced common data model, producing comprehensive and clinically detailed real-world data sourced from their proprietary electronic health records, iKnowMed. This extensive data collection reflects the entire patient journey, ensuring that insights can significantly enhance cancer treatment outcomes.
About Ontada and its Commitment to Cancer Care
Ontada, as part of the McKesson Corporation, is dedicated to driving innovation in cancer care through data and technology. Their mission is rooted in providing precise insights right when they are needed the most, ultimately saving lives. They connect the full spectrum of the patient's journey with advanced analytics, influencing care strategies adopted by leading life sciences companies globally.
Investing in Cancer Research and Care
As patients battling cancer face unprecedented changes in treatment availability and quality, Ontada is committed to addressing the complexities in oncology. This initiative is crucial as the demand for new and effective cancer therapies continues to grow. Ontada plays a significant role in this landscape, helping to accelerate innovation and improve patient outcomes by collaborating with healthcare providers and researchers.
Frequently Asked Questions
What is the purpose of Ontada's collaboration with Microsoft?
Ontada's collaboration with Microsoft aims to utilize Azure AI technologies to process unstructured oncology data effectively, improving clinical insights and patient outcomes.
What challenges does unstructured data present in healthcare?
Unstructured data poses significant challenges, as up to 80% of essential medical information remains unprocessed, leading to missed opportunities for analysis and improved patient care.
How does the ON.Genuity platform support oncology?
The ON.Genuity platform integrates advanced AI with a common data model to gather and analyze real-world data across the entire patient journey, ultimately enhancing cancer care quality.
What are Large Language Models (LLMs) in this context?
LLMs are advanced AI tools used by the Ontada Data Science team to identify critical oncology data points across numerous cancer types, improving the efficiency of data processing.
How does Ontada contribute to improving cancer research?
Ontada facilitates cancer research by providing real-world data and insights, which help healthcare providers and researchers make informed decisions for better patient care.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Understanding Short Interest Trends for Sweetgreen (SG)
- Understanding Target's Rising Short Interest Trends
- Innovative Alliance Between HealthRev and Trella Strengthens Care Agencies
- Concerns Arise Over Zuora's Buyout Deal and Its Implications
- Maximus Wins $300 Million IRS Contract for Enhanced Services
- DevRev Unveils Groundbreaking Conversational AI for SaaS 2.0
- Phillip Sarofim Joins National Air and Space Museum Board
- Cycle for Survival: Uniting Riders in the Fight Against Rare Cancers
- Fifth Third Foundation's $250,000 Aid for Hurricane Recovery
- Tech Sector Surges as AI Chip Demand Drives Market Gains
Recent Articles
- NUSO and Jenne Join Forces to Revolutionize Cloud Solutions
- The Big Biscuit's Commitment to Thoughtful Expansion and Growth
- Sunbird Bio Secures $14 Million for Advanced Neurological Diagnostics
- Tesla's Leadership Changes: Promotions for Key Executives
- Celebrating Innovation: Creality's Thriving 3D Printing Community
- California Pizza Kitchen Enhances Marketing Strategy for Growth
- Recent Developments Impacting Phillips 66 Stock Performance
- Insights on Financial Consolidation and Reporting for Businesses
- How Townhomes Are Shaping the Future of American Housing
- Mark Hara Takes the Helm as CEO of Layr: A New Era Begins
- Ladder Capital Corp: Preparing for Third Quarter Financials
- Huawei Unveils Innovative All-Optical Network Solutions
- Blackstone Reports Strong Q3 Results: Key Metrics and Insights
- SpiderOak Launches Open-Source Project for Cybersecurity Enhancement
- Infosys Reports Impressive Revenue Growth Amidst Challenges
- Bandwidth Inc. Launches Hurricane Relief Initiative for N.C.
- Bison Commerce Unveils New Brand Focus and Technology Investment
- Solubag USA, Inc. Secures Investment for Sustainable Expansion
- Hurricane Helene: Understanding the Flood Damage Risk
- VTS Experiences Remarkable Growth with VTS Activate Expansion
- Venture Valley Video Game Celebrated for Innovative Learning
- Mattel Films Takes View-Master to New Heights with Live-Action
- Nutella Biscuits and Betches Media Celebrate Reading Together
- Alcoa and IGNIS EQT Enhance Future Operations in Strategic Deal
- Proficient Auto Logistics Shares Q3 Financial Outlook for 2024
- U.S. Bancorp Stock: Recent Analyst Upgrades and Insights
- Lilypad Insurance Strengthens Market Presence with Acquisition
- UBS Upgrades TSMC Outlook with Enhanced Margin Expectations
- Cushman & Wakefield Improves Loan Terms and Reduces Debt
- Collaborative Breakthrough in Cell Therapy by Factor and Eterna
- Stifel Upgrades ULTA Beauty Price Target Amid Growth Plans
- UAE's Expand North Star Concludes with Record Global Innovation
- Guardian's Milestone Acquisition: The Louisa and Urban Renewal
- Great Southern Bancorp Stock Analysis: A Bright Future Ahead
- Infosys Reports Solid Revenue Growth and Strategic Partnerships
- E3 Lithium Celebrates Pilot Project Success with NRCan Support
- Nicolet Bankshares Sees Target Raise on Strong Earnings Growth
- American Rebel Holdings Strengthens NASDAQ Compliance Status
- Sage Therapeutics Implements Strategic Changes for ZURZUVAE
- Meta Platforms: Mizuho Sees Potential with Ad Growth and AI
- Exciting Advances in Gene Therapy Presented by AskBio
- Lexicon Pharmaceuticals Gains Momentum from Strategic Deal Insights
- Veriff Acknowledged as Leader in Enterprise Fraud Solutions
- PPG Concludes Sale of Architectural Coatings to AIP
- Axis Capital Adjusts Bajaj Auto Target to INR 8,000 Amid Caution
- Immutep Moves Forward with Breakthrough Trial of IMP761
- Mobix Labs Achieves Impressive Growth and Expands Market Reach
- US Power Demand Surge: Utilities Brace for Transformative Changes
- B. Riley Modifies Price Target Following GM and Lithium Deal
- Sunnova's Remarkable Resilience Amid Hurricanes Milton and Helene